Jesy Nelson has announced a significant achievement in her campaign for improved healthcare, confirming that the Spinal Muscular Atrophy (SMA) Type 1 screening test will now be implemented across the entire United Kingdom. Nelson expressed profound pride in the collective effort that led to this expansion, which she stated will fundamentally alter the lives of future babies diagnosed with SMA.
In January, Nelson revealed that her 14-month-old twins, Ocean and Story, were diagnosed with SMA Type 1, a rare and severe muscle-wasting condition. This personal experience fueled her advocacy, culminating in a recent conversation with health minister Sharon Hodgson and Secretary of State for Health and Social Care James Murray, who confirmed the nationwide rollout.
"It's an emotional day. I'm still taking it in to be honest. It’s amazing. It's just mind-blowing. I feel so proud," Nelson stated. "I just feel so proud of everyone that's been a part of getting it to this place because now future SMA baby’s lives are gonna look completely different. And that is all I ever wanted."
Previously, a parliamentary debate in March resulted in a decision that only 72 percent of England would have access to newborn screening when it was slated to begin in October, leaving the remaining 28 percent without. However, the government has now confirmed the expansion of the scheme, which will screen hundreds of thousands of babies starting in October.
SMA Type 1 is a debilitating condition that can prevent infants from sitting, crawling, or walking. In its most severe forms, it impairs breathing and swallowing. Early detection through newborn screening allows for timely treatment, which can significantly improve outcomes for affected children. The testing process involves a simple blood sample taken from a newborn via a heel prick.
Nelson highlighted the impact her daughters' story has had on driving this change. "I feel super proud that my girls' story has been a part of change and I can't wait when they're a bit older and they understand to be able to tell them that," she said. "I've always said I want this to be their little superpower and I feel now, when they understand, I can let them know that."
Reflecting on the earlier parliamentary decision, Nelson admitted to feeling "absolutely fuming" and "so let down." However, she maintained a positive outlook, crediting manifestation and community effort for the eventual success.
James Murray, Secretary of State for Health and Social Care, affirmed the government's commitment, stating, "No parent should have to watch their child lose the ability to move or breathe, knowing that earlier treatment could have made all the difference." He added that the expansion is "another step in the right direction as we do all we can to reduce health inequalities."
Giles Lomax, Chief Executive Officer of SMA UK, called the development a "hugely important step forward" after years of campaigning by the SMA community and partner organizations. "When newborn screening for SMA begins later this year in October, thousands of babies will benefit from earlier diagnosis and access to life-changing treatment," Lomax said. He also expressed gratitude to all involved and emphasized the goal of ensuring every newborn across the UK receives this test.
The SMA screening program in England is set to begin testing babies from October, ahead of schedule, following the government's commitment to expedite the rollout earlier this year.